This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
What is it? Inavolisib is a PI3Kα isoform-selective kinase inhibitor and monovalent degrader of the mutant p110α catalytic subunit of…
molecule
8 months ago ●
5 mins read
The FDA in 2021 approved four novel small molecule drugs for various infectious diseases, including human immunodeficiency virus type-1 (HIV-1),…
Article
1 year ago ●
12 mins read
A newly disclosed sGC activator in Ph. II for CKD/DKD. This month, researchers at BI reported promising preclinical results for…
molecule
8 months ago ●
4 mins read
In this highlight, Dr. Dennis C. Koester reviews treatment options for HIV and explains how small molecule long-acting injectables (LAIs)…
Article
1 year ago ●
7 mins read
What is it? DN-1289 is a CNS-penetrant, ATP-competitive DLK/LZK-selective dual kinase inhibitor intended to treat amyotrophic lateral sclerosis (ALS). The…
molecule
8 months ago ●
2 mins read
We did a comprehensive review of industry news in 2022Q1 (there was.. a lot of stuff to cover). In this…
Article
1 year ago ●
10 mins read
Load More
